Promising repurposed antiviral molecules to combat SARS-CoV-2: A review
COVID-19, an extremely transmissible and pathogenic viral disease, triggered a global
pandemic that claimed lives worldwide. To date, there is no clear and fully effective …
pandemic that claimed lives worldwide. To date, there is no clear and fully effective …
An overview of potential therapeutic agents to treat COVID-19
X Dong, Z Tian, C Shen, C Zhao - Bioscience trends, 2020 - jstage.jst.go.jp
The emerging novel coronavirus disease (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has swept across the world and become a global …
syndrome coronavirus 2 (SARS-CoV-2), has swept across the world and become a global …
Tackling SARS-CoV-2: proposed targets and repurposed drugs
The SARS-CoV-2 pandemic, declared as a global health emergency by the WHO in
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …
COVID-19: Innovative antiviral drugs required for long-term prevention and control of coronavirus diseases
The COVID-19 pandemic has had global catastrophic effects on financial markets, jobs and
peoples' lives. Future prevention/therapy of COVID-19 will rely heavily on vaccine …
peoples' lives. Future prevention/therapy of COVID-19 will rely heavily on vaccine …
Race to arsenal COVID-19 therapeutics: Current alarming status and future directions
The on-going pandemic of COVID-19 wreaked by a viral infection of SARS-CoV-2, has
generated a catastrophic plight across the globe. Interestingly, one of the hallmarks of …
generated a catastrophic plight across the globe. Interestingly, one of the hallmarks of …
Current scenario and future prospect in the management of COVID-19
P Borah, PK Deb, S Deka… - Current Medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
A Therapeutic Journey of Potential Drugs Against COVID-19
Coronavirus disease (CoVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) scrambles the world by infecting millions of peoples all over the globe. It …
2 (SARS-CoV-2) scrambles the world by infecting millions of peoples all over the globe. It …
After the hurricane: Anti-COVID-19 drugs development, molecular mechanisms of action and future perspectives
HO Khalifa, YM Al Ramahi - International Journal of Molecular Sciences, 2024 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a new coronavirus in
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Current perspective of antiviral strategies against COVID-19
COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …